Preclinical evaluation of a new topical corticosteroid methylprednisolone aceponate
Authors:
- 1 April 1994
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 3 (s1) , S32-S38
Abstract
Objective: Preclinical characterization of methylprednisolone aceponate.Results: The local antiinflammatory potency of methylprednisolone aceponate was equal to the very strong glucocorticoid clobetasol 17‐propionate but higher than the potency of hydrocortisone 17‐butyrate after topical application in 2 animal models of inflammation. Methylprednisolone aceponate is activated enzymatically in the skin. This activation proceeds faster in inflamed tissue. In contrast to clobetasol 17‐propionate, methylprednisolone aceponate was devoid of systemic effects after topical application for 3 days. Finally, whereas clobetasol 17‐propionate induced marked skin atrophy, methylprednisolone aceponate induced only slight atrophogenic changes after long‐term application (up to 43 days) on rat skin, comparable to the effects of hydrocortisone 17‐butyrate.Conclusions: Methylprednisolone aceponate combines high local antiinflammatory potency with very low systemic side effects and only minor local atrophogenic activity. The reason for the dissociation between local antiinflammatory and atrophogenic effects is not known so far. It may be speculated that one of the reasons for the very strong local antiinflammatory activity may reside in the faster enzymatic activation in inflamed tissue. Methylprednisolone aceponate represents a new corticosteroid with which it is possible to improve the dissociation between desired antiinflammatory activity and undesired side effects of topical glucocorticoids.Keywords
This publication has 13 references indexed in Scilit:
- Methylprednisolone aceponate (MPA)* — a new therapeutic for eczema: A pharmacological overviewJournal of Dermatological Treatment, 1992
- New developments in corticosteroid researchJournal of Dermatological Treatment, 1990
- The Influx of Inflammatory Cells into Nasal Washings during the Late Response to Antigen Challenge: Effect of Systemic Steroid PretreatmentAmerican Review of Respiratory Disease, 1988
- Perspectives in Corticosteroid ResearchDrugs, 1988
- Relationship between macrophage infiltration and epidermopoiesis in delayed-type hypersensitivityArchives of Dermatological Research, 1988
- The cellular inflammatory response in nicotinate skin reactionsBritish Journal of Dermatology, 1987
- Corticoids and Cultured Human Epidermal Keratinocytes: Specific Intracellular Binding and Clinical EfficacyJournal of Investigative Dermatology, 1981
- Studies on the stability of corticosteroids VI. Kinetics of the rearrangement of betamethasone-17-valerate to the 21-valerate ester in aqueous solutionInternational Journal of Pharmaceutics, 1981
- A Bio-ass ay for the Concomitant Assessment of the Antiphlogistic and Thymolytic Activities of Topically Applied CorticoidsEndocrinology, 1965
- Percutaneous Corticosteroid Absorption Correlated to Partition CoefficientJournal of Pharmaceutical Sciences, 1965